United Kingdom Pen Needles Market Insight
United Kingdom Pen Needles Market is growing at an 10.55% CAGR, driven by increasing hepatitis B prevalence, antiviral adoption
United Kingdom Pen Needles Market Insights Forecasts to 2035
- The United Kingdom Pen Needles Market Size Was Estimated at USD 263.7 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 10.55% from 2025 to 2035
- The United Kingdom Pen Needles Market Size is Expected to Reach USD 719.2 Million by 2035
Notable Insights for United Kingdom Pen Needles Market
- By product type, standard pen needles dominated, accounting for approximately 65% share in 2024, driven by widespread insulin pen usage and affordability.
- By needle length, 4mm and 5mm pen needles dominated, holding approximately 68% share, due to improved patient comfort and reduced injection pain.
- Approximately 4.9 million people in the UK are living with diabetes, with a significant proportion requiring daily insulin administration using pen devices.
- Around 75% of insulin-dependent diabetic patients prefer pen injectors over conventional syringes due to convenience, portability, and dosing accuracy.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Pen Needles Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Pen Needles Market
- Novo Nordisk
- Becton Dickinson (BD)
- Owen Mumford
- Ypsomed
- Terumo Corporation
- Embecta
- Artsana Group
- Allison Medical
- Others
Recent Developments:
- In August 2025, Trividia Health UK launched TRUEplus 5-Bevel Pen Needles in the UK, improving injection comfort, reducing pain, and supporting enhanced diabetes management and patient adherence nationwide.
- In February 2025, Owen Mumford promoted Unifine® SafeControl® safety pen needles in the UK, enhancing insulin injection safety through audible and visual lock confirmation while reducing needlestick injury risks.
Market Segmentation:
United Kingdom Pen Needles Market, By Product Type
- Standard Pen Needles
- Safety Pen Needles
- Dual Therapy Pen Needles
- Others
United Kingdom Pen Needles Market, By Needle Length
- 4mm
- 5mm
- 6mm
- 8mm and Above
United Kingdom Pen Needles Market, By End User
- Hospitals & Clinics
- Home Care Settings
- Diabetes Care Centres
United Kingdom Pen Needles Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Expert Views:
The UK Pen Needles Market is expected to witness stable growth due to increasing diabetes prevalence, expanding insulin therapy adoption, and rising preference for home-based care. Experts emphasize that shorter and ultra-thin pen needles will continue dominating the market because of improved comfort, reduced pain, and better patient compliance. NHS initiatives supporting diabetes management, combined with innovations in safety-engineered pen needles and enhanced injection technologies, are anticipated to accelerate market expansion and improve long-term treatment adherence through 2035.